Results

Total Results: 1,640 records

Showing results for "therapy".

  1. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
    November 01, 2021 - therapies. … , digital gamified cognitive therapies, EndeavorRx, play therapy, play-based interventions, mindfulness-based … ): Specific treatments compared with other treatments as described above or to no treatment KQ 3 (monitoring … Therapies"[MeSH] OR "Combined Modality Therapy"[MeSH] ADHD Systematic Review Protocol … ] OR "alternative therapy"[tiab] OR "alternative therapies"[tiab] OR "Interpersonal skills training"
  2. effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
    February 01, 2008 - is contraindicated; failure of anticoagulant therapy in thromboembolic diseases; emergency treatment … is contraindicated; failure of anticoagulant therapy in thromboembolic diseases; emergency treatment … is contraindicated; failure of anticoagulant therapy in thromboembolic diseases; emergency treatment … is contraindicated; failure of anticoagulant therapy in thromboembolic diseases; emergency treatment … and name for IVC filters), mobilization status of the patients, use of concurrent standard medical therapies
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
    February 01, 2008 - is contraindicated; failure of anticoagulant therapy in thromboembolic diseases; emergency treatment … is contraindicated; failure of anticoagulant therapy in thromboembolic diseases; emergency treatment … is contraindicated; failure of anticoagulant therapy in thromboembolic diseases; emergency treatment … is contraindicated; failure of anticoagulant therapy in thromboembolic diseases; emergency treatment … and name for IVC filters), mobilization status of the patients, use of concurrent standard medical therapies
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
    March 25, 2012 - have been studied, in comparison with hormone therapy or placebo, primarily as treatment of vasomotor … Treatments of interest include: • Hormone therapies o Oral estrogen only or combined with progestin … “therapy” [Subheading] OR “Therapeutics”[Mesh] OR “Estrogen Replacement Therapy”[Mesh] OR “Drug Therapy … ”[Mesh] OR “drug therapy” [Subheading] OR “therapeutic use” [Subheading] OR “Hormone Replacement Therapy … ’/exp OR ‘therapeutics’/exp OR ‘estrogen replacement therapy’/exp OR ‘drug therapy’/exp OR ‘therapeutic
  5. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - new (and new uses of existing) pharmaceuticals, medical devices, diagnostic tests and procedures, therapeutic … , screening and diagnostics, therapeutics, surgery, programs, and care delivery innovations that address … When these therapies fail to achieve relief, surgical treatments may be proposed, such as arthroplasty … Current treatments for OA include over-the-counter pain medication, exercise and/or physical therapy … Autologous MSCs have also been given with other therapies, including platelet-rich plasma (PRP) therapy
  6. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
    December 05, 2013 - When these therapies fail to achieve relief, surgical treatments may be proposed, such as arthroplasty … Current treatments for OA include over-the-counter pain medication, exercise and/or physical therapy … Autologous MSCs have also been given with other therapies, including platelet-rich plasma (PRP) therapy … of treatments required. … The cost of one PRP treatment was purported to be lower than the cost of three hyaluronic acid treatments
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-e.xlsx
    July 09, 2025 - Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix E Table Table
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/procalcitonin_research-protocol.pdf
    September 08, 2011 - Rapid diagnosis of sepsis and early initiation of antibiotic and goal-directed therapies have demonstrated … o Were participants in treatment groups recruited in the same time period? … o Were concurrent/concomitant treatments clearly specified and given equally to treatment groups? … because they convey the possibility of determining differences in the relative efficacy of two treatments … Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
    September 27, 2012 - Treatment Indications Two major indications for liver-directed therapies exist: 1. … Current Treatments Several liver-directed therapies have been developed to treat patients with CRC … and harms of the various palliative treatments. … Comparators KQ 1 & 2: • All the therapies will be compared to each other as treatment of patients … o Were concurrent/concomitant treatments clearly specified and given equally to treatment groups?
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment_research-protocol.pdf
    September 29, 2011 - their therapeutic goal. … In addition to aggressive medical therapy, two treatment pathways have emerged for treating patients … Presentation Treatment Optimal medical therapy PCI* CABG* STEMI X X NSTEMI/ unstable angina … Adding the effect of different therapies on cognition. … currently in use (such as specific components of treatments considered to be ―optimal medical therapy
  11. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive-2007.pdf
    January 01, 2007 - management era (i.e., since JNC-5 in 19931), what is the evidence on the effects of aggressive medical therapy … Effectiveness Reviews, the program supports systematic appraisals of existing scientific evidence regarding treatments … What adverse events and complications have been associated with aggressive medical therapy or renal artery … Notably, only two trials have compared angioplasty (without stent placement) with medical therapy and … alone or medical therapy followed by angioplasty at 3 months found either no significant differences
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
    June 12, 2013 - have been studied, in comparison with hormone therapy or placebo, primarily as treatment of vasomotor … Treatments of interest include: • Hormone therapies o Oral estrogen only or combined with progestin … “therapy” [Subheading] OR “Therapeutics”[Mesh] OR “Estrogen Replacement Therapy”[Mesh] OR “Drug Therapy … ”[Mesh] OR “drug therapy” [Subheading] OR “therapeutic use” [Subheading] OR “Hormone Replacement Therapy … ’/exp OR ‘therapeutics’/exp OR ‘estrogen replacement therapy’/exp OR ‘drug therapy’/exp OR ‘therapeutic
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
    May 01, 2012 - advantage of the incident user design is that it can capture the clinical consequences of an entire therapeutic … The risk of myocardial infarction associated with antihypertensive drug therapies. … Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled … Structural accelerated failure time models for survival analysis in studies with time- varying treatments … A review of uses of health care utilization databases for epidemiologic research on therapeutics.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
    January 01, 2014 - Although we are clear throughout that these are unique diseases with unique treatments, a title change … Supplemental treatment may include physical therapy, occupational therapy, and treatment- related surgery … Supplemental treatment may include physical therapy, occupational therapy, and treatment-related surgery … Adjunct treatments. It describes splenectomy as an option for supportive care. … We did not investigate any combination therapies for LSDs.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0174_10-20-2009.pdf
    January 01, 2009 - devices Comparator(s): See above interventions and no treatment Outcome(s): Intermediate outcomes … What is the effectiveness and comparative effectiveness of physical and rehabilitative treatments available … What are the associated risks, adverse effects, and potential harms of physical and rehabilitative therapies … There is some indication that non-pharmacologic therapies are underutilized in patients with OA and … A review that evaluates the effectiveness of treatments and gaps that remain in the evidence for patient
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause_disposition-comments.pdf
    March 05, 2015 - Menopausal Symptoms: Comparative Effectiveness of Therapies. … Major comment 3: The terminology of “hormone therapy” should be changed to “menopausal hormone therapy … that most times, the authors mean “menopausal hormone therapy” when they say “hormone therapy.” … Why not include non-medication treatments for menopausal symptoms in this report? … lines 63 Tamoxifen, alone or in combination with another treatment?
  17. effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/improved-cancer-outcomes-protocol_0.pdf
    December 01, 2021 - characteristics (cancer type, treatment type (systemic therapy, radiation, surgery), stage of disease … cancer diagnosis and initiation of any cancer therapy (e.g., systemic therapy, radiation, surgery). … (at least in part) w ith cancer therapy (e.g., systemic therapy, radiation, surgery), regardless of … (at least in part) w ith cancer therapy (e.g., systemic therapy, radiation, surgery), regardless of … draft report, the search will be conducted from 2000 to December 2021 to encompass contemporary cancer treatments
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_disposition-comments.pdf
    November 27, 2012 - In the former, practitioners move to another therapeutic choice and in the latter, study subjects drop … Although therapies may be stopped after 12 to 16 weeks in patients who fail treatment, there are patients … who are on these therapies much longer than 16 weeks when therapies are successful. … Thus, ustekinumab is by far the most convenient therapy. … Amgen has conducted many clinical trials in the inflammation therapeutic area to demonstrate the safety
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d3.xlsx
    January 01, 2025 - Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D3 Tables … PSA, Gleason score, T stage, TURP, ADT, abdominal surgery, GI comorbidity, prostate volume, and SV treatment … Seminal vesicle treatment group interaction p-value was statistically significant (p=0.032) but specific … Seminal vesicle treatment group interaction p-value was statistically significant (p=0.032) but specific … NR NR NR NR NR NR NR NR NR 0.96 NR NR NR 0.77 1.2 NR NR 1206 No NR NR Adjusted : Neoadjuvant hormone therapy
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
    September 01, 2014 - Treatments for ASD focus on improving core deficits in social communication, addressing challenging … Individual goals for treatment vary by child, and a combination of therapies is used to achieve these … ., settings), components of multicomponent therapies that drive effectiveness, and predictors of treatment … � Re-evaluating potential treatments as research evolves. … � Available evidence on each program or therapy.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: